RE:The Rise In CMED SP Over $24 Is EXHIBIT A Of $725M Lawsuit. All shareholders of ACB saw the lawsuit as a joke and just a desperate act of CanM to try a curve ball. It didn’t work and had to come back to ACB to try and negotiate a deal that was going to get done regardless of management.